AI assistant
Aeffe — Board/Management Information 2026
May 14, 2026
4140_rns_2026-05-14_421de8e6-3bb7-420f-9415-7493a9d8ce2b.pdf
Board/Management Information
Open in viewerOpens in your device viewer
teleborsa
| Informazione Regolamentata n. 0923-32-2026 | Data/Ora Inizio Diffusione 14 Maggio 2026 17:35:54 | Euronext Milan |
|---|---|---|
Societa': AEFFE
Utenza - referente: AEFFEN01 - Degano Giulia
Tipologia: REGEM; 3.1
Data/Ora Ricezione: 14 Maggio 2026 17:35:54
Oggetto: 2026-05-14 Aeffe PR-Balance postponement and new appointments
Testo del comunicato
Vedi allegato
AEFFE
AEFFE SPA:
-
The Board of Directors approves the postponement of the approval of the 2025 budget – resulting in a subsequent change to the 2026 financial calendar.
-
SIMONE BADIOLI APPOINTED INVESTOR RELATOR
-
MARCO PIAZZI APPOINTED MANAGER IN CHARGE OF PREPARATION
San Giovanni in Marignano, 14 May 2026. Following the press release of 12 May 2026, Aeffe SpA (Aeffe or the Company) – a company listed on the Euronext Milan market of the Italian Stock Exchange, a leader in the fashion and luxury sector – announces that today the Board of Directors resolved to postpone the approval of the draft financial statements and consolidated financial statements to December 31, 2025, and, consequently, the related approval of the financial statements by the Shareholders' Meeting, beyond the deadline of 180 days from the end of the financial year.
This postponement was made necessary by the ongoing restructuring process, the outcome of which depends on the progress of discussions initiated with Oxy Italia Srl regarding the non-binding offer submitted by the latter as the leader of a consortium of industrial and financial partners currently being structured, the finalization of the strategic plan underlying the intervention envisaged by the offer itself, and the obtaining of new financing to support the Company's operations until the transaction is completed. An authorization application is expected to be filed pursuant to Article 22 of the Italian Corporate Crisis Code.
In consideration of the timing envisaged in the non-binding offer cited above, the Board of Directors has consequently approved the updated 2026 Financial Calendar, as follows:
June 30, 2026: Board of Directors meeting to approve the draft statutory and consolidated financial statements as of December 31, 2025, and related conference call at 4:00 p.m.
July 30, 2026: Board of Directors meeting to approve the 2026 half-yearly report and related conference call at 4:00 p.m.
July 31, 2026: Annual Shareholders' Meeting to approve the separate and consolidated financial statements as of December 31, 2025, and appoint the corporate bodies.
The updated Financial Calendar is also available on the Company website (aeffe.com – Investors Relations section).
Further to the press release of April 29, 2026, we also announce that today the Board of Directors appointed Simone Badioli, CEO and director of the Company, as Investor Relator, and Marco Piazzi, director of the Company, as Manager responsible for preparing the company's financial reports pursuant to Article 154-bis of Legislative Decree 58/1998 (TUF). Dr. Badioli and Dr. Piazzi will assume these roles effective tomorrow, May 15, 2026.
The appointment as Financial Reporting Officer was also made pursuant to paragraph 5-ter of Article 154- bis of the TUF, subject to the favorable opinion of the Board of Statutory Auditors and in compliance with the applicable professional requirements. The Board of Directors also granted Mr. Piazzi the powers provided for by law and the bylaws, verifying his suitability for the performance of the related duties.
Dr. Piazzi has extensive experience in administration, finance, and control, gained in part through his role as director and general manager of Pollini SpA.
Simone Badioli and Marco Piazzi replace Rocco Bennici in the aforementioned roles, who will continue to hold the role of CFO until the effective date of his resignation (9 June 2026).
Based on the information available to the Company, as of today, Dr. Piazzi does not own Aeffe shares, while Dr. Badioli owns 282,942 Aeffe shares.
Contacts
Investor Relations
AEFFE Spa
[email protected]
+39 0541 965211
Press Relations
AEFFE Spa
Alessandra Turra
[email protected]
+39 02 76059206
| Fine Comunicato n.0923-32-2026 | Numero di Pagine: 4 |
|---|---|